Brain Scientific announced a new distribution agreement with Fulcrum to drive sales. Fulcrum, a leader in the sales and marketing of B2B medical products, will help Brain Scientific further expand its sales and distribution network to the places the company sees as key growth markets as it continues to position itself as the leader in the quickly emerging medical wearables space.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.75 USD | -31.82% | -.--% | -.--% |
2023 | Brain Scientific Inc. cancelled the acquisition of IMAC Holdings, Inc.. | CI |
2023 | Brain Scientific Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 932K | |
+7.84% | 218B | |
+7.35% | 184B | |
+13.04% | 135B | |
+26.03% | 107B | |
-1.33% | 62.38B | |
+11.80% | 51.37B | |
+4.81% | 50.9B | |
+0.30% | 40.87B | |
+2.78% | 36.28B |
- Stock Market
- Equities
- BRSF Stock
- News Brain Scientific Inc.
- Brain Scientific Announces a New Distribution Agreement with Fulcrum to Drive Sales